This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Assistance Publique-Hopitaux De Paris, Centre National De La Recherche Scientifique, Institut Du Cerveau Et De La Moelle Epiniere. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:




Years Active: 2020
Title: Gael Le Douaron: Innovator in Neurodegenerative Disorder Treatments
Introduction
Gael Le Douaron is a notable inventor based in Verrières-le-Buisson, France. He has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative disorders. His innovative work has led to the development of unique compounds that hold promise for improving patient outcomes.
Latest Patents
Gael Le Douaron holds a patent for "1, 4, 8-triazaphenanthrene derivatives for the treatment of neurodegenerative disorders." This invention relates to compounds of formula (I), which are particularly useful as medicaments for the treatment or prevention of neurodegenerative disorders. The patent also covers the methods for producing these compounds and the pharmaceutical compositions that contain them. He has 1 patent to his name.
Career Highlights
Throughout his career, Gael has worked with esteemed organizations such as the Institut du Cerveau et de la Moelle Épinière and the Centre National de la Recherche Scientifique. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Bruno Figadere and Laurent Ferrie. Their collaborative efforts have further advanced the research and development of treatments for neurodegenerative disorders.
Conclusion
Gael Le Douaron's innovative contributions to the field of neurodegenerative disorder treatments highlight his importance as an inventor. His work continues to inspire advancements in medical research and pharmaceutical development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile